Globus Medical Inc. Class A Common Stock vs iShares Semiconductor ETF — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while iShares Semiconductor ETF trades at $504.17 (market cap $42.65B). The key difference: iShares Semiconductor ETF is far larger — about 4.2× Globus Medical Inc. Class A Common Stock's market cap, and iShares Semiconductor ETF is trading nearer its 52-week high, Globus Medical Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and iShares Semiconductor ETF for 47 Days on average.
| GMED | SOXX | |
|---|---|---|
Market Cap | $10.25B | $42.65B |
Volume | 1,059,528 | 10,736,485 |
Sector | Health | Sector/Thematic |
52-Week High | $96.82 | $655.01 |
52-Week Low | $58.33 | $268.10 |
Typical Hold Time | 0 Days | 47 Days |
Enterprise Value | $9.76B | — |
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
SOXX trades at $543.9, down 0.17% with a bearish technical signal. The ETF faces mixed sentiment as AI-driven semiconductor demand fuels optimism, but high valuations and Michael Burry's short positions highlight risks. Recent news shows strong September performance (+11%) and positive earnings revisions, though technical indicators suggest near-term pressure with support at $531.
Outlook hinges on AI infrastructure growth, with BofA projecting the semiconductor market to nearly double by 2030. Risks include valuation concerns (P/E of 68.79 per Seeking Alpha), concentration in top holdings, and macroeconomic volatility. Earnings growth remains a key catalyst, but investors should weigh high multiples against sector momentum.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →SOXX provides investors with exposure to U.S. companies that design, manufacture, and distribute semiconductors. It tracks the ICE Semiconductor Index, offering a targeted investment in the technology sector's foundational components, including firms that produce chips, related equipment, and services. SOXX is a key vehicle for investors seeking to capitalize on trends in artificial intelligence, 5G, and other technologies that rely heavily on advanced semiconductor technology.
Read more on SOXX →